EuroImmun is a German diagnostics biotech, founded by the most charming Professor Stöcker and recently sold to PerkinElmer. Elisabeth Bik checked some of company’s papers, many coauthored by Stöcker himself, and she raised questions. The company says this “testifies to a lack of knowledge of the matter”.
Plan S, designed by the former EU Commissioner Robert-Jan Smits, became a complete and chaotic mess where everyone, including the members of the signatory cOAlition S of research founders, does whatever they want. I learned all that while participating at the Academic Publishing Europe (APE) conference in Berlin, on 15-16 January.
Professor Ruben Plentz chose to focus his career on clinical medicine in Bremen, despite his tremendous academic achievements in cancer research. Was it because malicious critics harassed him with frivolous investigations and corrections, envious at all those peer-reviewed cancer cures the great doctor invented?